Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1991
African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesisJ Pepin, F Milord
Epidemiology and Infection|March 29, 2018
Morbidity, mortality and long-term sequelae of West Nile virus disease in QuébecN Ouhoumanne, A-M Lowe, A Fortin, et al.
Medecine Tropicale : Revue Du Corps De Sante Colonial|January 1, 1989
[Human African trypanosomiasis and normality of the cerebrospinal fluid]J Pepin, F Milord, C Guern
Canadian Family Physician Medecin De Famille Canadien|January 5, 2002
Vaccination practices of Quebec family physicians. Influenza vaccination status and professional practices for influenza vaccinationG Baron, P De Wals, F Milord
Evaluation & the Health Professions|March 10, 2001
Cost-effectiveness of a lottery for increasing physicians' responses to a mail surveyG Baron, P De Wals, F Milord
The Canadian Journal of Infectious Diseases = Journal Canadien Des Maladies Infectieuses|December 27, 2007
Evaluation of the rubella surveillance system in QuebecL Perron, P De Wals, F Milord
Bulletin of the World Health Organization|January 1, 1989
[Integration of African human trypanosomiasis control in a network of multipurpose health centers]J Pepin, C Guern, F Milord, et al.
Lancet (London, England)|December 19, 1987
Difluoromethylornithine for arseno-resistant Trypanosoma brucei gambiense sleeping sicknessJ Pepin, F Milord, C Guern, et al.
Lancet (London, England)|September 12, 1992
Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sicknessF Milord, J Pépin, L Loko, et al.
The American Journal of Tropical Medicine and Hygiene|August 1, 1992
The impact of human immunodeficiency virus infection on the epidemiology and treatment of Trypanosoma brucei gambiense sleeping sickness in Nioki, ZaireJ Pepin, L Ethier, C Kazadi, et al.
Pageof 14